Global Opioid Use Disorder Market

Table of Content

1. Introduction

   • Definition of Opioid Use Disorder (OUD) Market

     • Scope of the Report

2. Methodology

   • Executive Summary

   • Market Overview

   • Market Definition and Segmentation

3. Market Dynamics

   • Drivers

   • Restraints

   • Opportunities

   • Porter's Five Forces Analysis

   • PESTEL Analysis

4. Opioid Use Disorder (OUD) Market, By Drug Class:

   • Buprenorphine

   • Methadone

   • Naltrexone

5. Opioid Use Disorder (OUD) Market, By Route of Administration:

   • Oral

   • Parenteral

6. Opioid Use Disorder (OUD) Market, By Distribution Channel:

   • Hospitals Pharmacies

   • Retail Pharmacies & Stores

   • Online Pharmacies

7. Opioid Use Disorder (OUD) Market, By Geography

   • North America

     • United States

     • Canada

   • Europe

     • United Kingdom

     • Germany

     • France

     • Spain

     • Italy

     • Rest of Europe

   • Asia-Pacific

     • China

     • Japan

     • India

     • South Korea

     • Australia

     • Rest of Asia-Pacific

   • Latin America

     • Brazil

     • Mexico

     • Rest of Latin America

   • Middle East & Africa

     • Saudi Arabia

     • United Arab Emirates

     • South Africa

     • Rest of Middle East & Africa

8. Competitive Landscape

9. Company Profiles

   • Indivior PLC

     • Company Overview

     • Product Portfolio and Description

     • Key Highlights

     • Financial Overview

   • Alkermes

   • Orexo AB

   • Titan Pharmaceuticals, Inc.

   • Mallinckrodt Pharmaceuticals

   • BioDelivery Sciences International Inc.

   • Viatris Inc. (Mylan N.V.)

   • Hikma Pharmaceuticals PLC

   • Camurus

10. Conclusion and Future Outlook

    • Appendix

    • Research Methodology

    • About the Pharmanucleus

11. Disclaimer